Bayesian reanalysis of early remdesivir for the treatment of COVID-19 in outpatients with high risk of progression to severe disease. Abdelghany M, Yu F, Rennard S, Gwon Y, et al. PLoS One 2026;21:e0346878.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Abdelghany M, Yu F, Rennard S, Gwon Y, et al. Bayesian reanalysis of early remdesivir for the treatment of COVID-19 in outpatients with high risk of progression to severe disease. PLoS One 2026;21:e0346878.
PMID: 41990093